These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 34588861)

  • 1. Identifying key genes and screening therapeutic agents associated with diabetes mellitus and HCV-related hepatocellular carcinoma by bioinformatics analysis.
    Sufyan M; Ali Ashfaq U; Ahmad S; Noor F; Hamzah Saleem M; Farhan Aslam M; El-Serehy HA; Aslam S
    Saudi J Biol Sci; 2021 Oct; 28(10):5518-5525. PubMed ID: 34588861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma.
    Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J
    Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 4. Construction of miRNA-mRNA network for the identification of key biological markers and their associated pathways in IgA nephropathy by employing the integrated bioinformatics analysis.
    Noor F; Saleem MH; Aslam MF; Ahmad A; Aslam S
    Saudi J Biol Sci; 2021 Sep; 28(9):4938-4945. PubMed ID: 34466069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of significant gene and pathways involved in HBV-related hepatocellular carcinoma by bioinformatics analysis.
    Xie S; Jiang X; Zhang J; Xie S; Hua Y; Wang R; Yang Y
    PeerJ; 2019; 7():e7408. PubMed ID: 31392101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
    Tang Y; Zhang Y; Hu X
    Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
    Yang Z; Wu X; Li J; Zheng Q; Niu J; Li S
    Int J Gen Med; 2021; 14():10185-10194. PubMed ID: 34992437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Chen X; Liao L; Li Y; Huang H; Huang Q; Deng S
    Biomed Res Int; 2020; 2020():7653506. PubMed ID: 33102593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis.
    Zhou L; Du Y; Kong L; Zhang X; Chen Q
    Onco Targets Ther; 2018; 11():1861-1869. PubMed ID: 29670361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying potential prognosis markers in hepatocellular carcinoma
    Hu X; Zhou J; Zhang Y; Zeng Y; Jie G; Wang S; Yang A; Zhang M
    Front Genet; 2022; 13():942454. PubMed ID: 35928445
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
    Yang SY; Ren H; Li CF; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.
    Li Z; Lin Y; Cheng B; Zhang Q; Cai Y
    Front Genet; 2021; 12():571231. PubMed ID: 33767726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of key genes and pathways in hepatocellular carcinoma: A preliminary bioinformatics analysis.
    Wu M; Liu Z; Zhang A; Li N
    Medicine (Baltimore); 2019 Feb; 98(5):e14287. PubMed ID: 30702595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of differentially expressed genes and immune cell infiltration in the progression of nonalcoholic steatohepatitis (NASH) to hepatocellular carcinoma (HCC): a new exploration based on bioinformatics analysis.
    Liu Y; Yu X; Wang Y; Wu J; Feng B; Li M
    Nucleosides Nucleotides Nucleic Acids; 2024 Feb; ():1-16. PubMed ID: 38319987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus.
    Li Z; Xu J; Cui H; Song J; Chen J; Wei J
    Medicine (Baltimore); 2020 May; 99(20):e20302. PubMed ID: 32443377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of hub genes and candidate drugs in hepatocellular carcinoma by integrated bioinformatics analysis.
    Chen X; Xia Z; Wan Y; Huang P
    Medicine (Baltimore); 2021 Oct; 100(39):e27117. PubMed ID: 34596112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Drug Targets and Agents Associated with Hepatocellular Carcinoma through Integrated Bioinformatics Analysis.
    Hossen MA; Reza MS; Harun-Or-Roshid M; Islam MA; Siddika MA; Mollah MNH
    Curr Cancer Drug Targets; 2023; 23(7):547-563. PubMed ID: 36786134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.